Trial Profile
A Pilot Phase I Open Label Study of Cu-64-TP3805 PET Imaging for Detection of Prostate Cancer in Men With Persistently Elevated PSA
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs NLS VPAC1 (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 25 Jun 2019 Status changed from recruiting to completed.
- 11 Apr 2019 Planned End Date changed from 1 Feb 2019 to 1 Mar 2020.
- 11 Apr 2019 Planned primary completion date changed from 1 Jan 2019 to 1 Jul 2019.